<SEC-DOCUMENT>0001354488-11-004563.txt : 20111116
<SEC-HEADER>0001354488-11-004563.hdr.sgml : 20111116
<ACCEPTANCE-DATETIME>20111116172051
ACCESSION NUMBER:		0001354488-11-004563
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20111115
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20111116
DATE AS OF CHANGE:		20111116

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AE BIOFUELS, INC.
		CENTRAL INDEX KEY:			0000738214
		STANDARD INDUSTRIAL CLASSIFICATION:	INDUSTRIAL ORGANIC CHEMICALS [2860]
		IRS NUMBER:				261407544
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-51354
		FILM NUMBER:		111210895

	BUSINESS ADDRESS:	
		STREET 1:		20400 STEVENS CREEK BLVD
		STREET 2:		SUITE 700
		CITY:			CUPERTINO
		STATE:			CA
		ZIP:			95014
		BUSINESS PHONE:		408-517-3304

	MAIL ADDRESS:	
		STREET 1:		20400 STEVENS CREEK BLVD
		STREET 2:		SUITE 700
		CITY:			CUPERTINO
		STATE:			CA
		ZIP:			95014

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AE Biofuels, Inc.
		DATE OF NAME CHANGE:	20071212

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MARWICH II LTD
		DATE OF NAME CHANGE:	19840123
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>aebf_8k.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<html>
<head>
    <title>aebf_8k.htm</title>
    <!--Licensed to: Issuer Direct Corp.-->
    <!--Document Created using EDGARizerAgent 5.4.1.0-->
    <!--Copyright 1995 - 2009 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="4">
<hr style="MARGIN-TOP: -10px; COLOR: #000000" noshade size="1">
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">UNITED STATES</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">SECURITIES AND EXCHANGE COMMISSION</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">WASHINGTON, D.C. 20549</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 14pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 14pt; FONT-WEIGHT: bold">FORM 8-K</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">CURRENT REPORT</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Date of Report (Date of earliest event reported): November 15, 2011</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 14pt; FONT-WEIGHT: bold; TEXT-DECORATION: underline">AE BIOFUELS, INC.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(Exact name of registrant as specified in its charter)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>

<div align="center">
<table cellpadding="0" cellspacing="0" width="80%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="30%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Nevada</font></div>
</td>
<td valign="bottom" width="5%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="30%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">000-51354</font></div>
</td>
<td valign="bottom" width="5%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" width="30%" style="BORDER-BOTTOM: black 2px solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">26-1407544</font></div>
</td>
</tr><tr>
<td valign="bottom" width="30%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(State or Other Jurisdiction</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">of Incorporation)</font></div>
</td>
<td valign="bottom" width="5%"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="30%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(Commission</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">File Number)</font></div>
</td>
<td valign="bottom" width="5%"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="30%">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(I.R.S. Employer</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Identification No.)</font></div>
</td>
</tr></table>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">20400 Stevens Creek Blvd., Suite 700</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-DECORATION: underline">Cupertino, California 95014</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(Address of Principal Executive Office) (Zip Code)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-DECORATION: underline">(408) 213-0940</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(Registrant&#8217;s telephone number, including area code)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold; TEXT-DECORATION: underline">N/A</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(Former name or former address, if changed since last report)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Wingdings">o </font>Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Wingdings">o </font>Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Wingdings">o </font>Pre-commencement communications pursuant to Rule&#160;14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Wingdings">o </font>Pre-commencement communications pursuant to Rule&#160;13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman, serif; FONT-SIZE: 1pt">&#160;</font></div>

<div>
<hr style="MARGIN-TOP: -5px; COLOR: #000000" noshade size="1">
<hr style="MARGIN-TOP: -13px; COLOR: #000000" noshade size="4">
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: white" align="center" noshade size="2" width="100%">
</div>
</div>

<div id="HDR"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ITEM 5.03 AMENDMENTS TO ARTICLES OF INCORPORATION OR BYLAWS; CHANGE IN FISCAL YEAR.</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Effective November 15, 2011, we amended our articles of incorporation to change our name from AE Biofuels, Inc. to Aemetis, Inc.&#160;&#160;In connection with this name change, the Financial Industry Regulatory Authority (&#8220;FINRA&#8221;) assigned the Company a new CUSIP number and trading symbol:</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">New CUSIP Number: 00770K103</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">New Trading Symbol: AMTX</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">This name change was effective under Nevada corporate law as of November 15, 2011, pursuant to a Certificate of Amendment previously filed with the Nevada Secretary of State on October 6, 2011.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ITEM&#160;7.01 REGULATION FD DISCLOSURE.</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On November 15, 2011, the Company issued a press release announcing the name change to Aemetis, Inc.&#160;&#160;A copy of the press release is attached hereto as Exhibit 99.1 to this Current Report and is incorporated herein by reference. The information contained herein and the attached exhibit are furnished under this Item 7.01 of this Current Report and are furnished to, but for purposes of Section 18 of the Securities Exchange Act of 1934 shall not be deemed filed with, the Securities and Exchange Commission. The information contained herein and in the accompanying exhibit shall not be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing, unless expressly incorporated therein.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS</font></div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(d) Exhibits</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div align="left">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold">Exhibit Number</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left; PADDING-BOTTOM: 2px"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold">&#160;</font></td>
<td valign="bottom" style="BORDER-BOTTOM: black 2px solid"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 8pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 8pt; FONT-WEIGHT: bold">Description</font></font></td>
</tr><tr>
<td valign="bottom"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr bgcolor="#cceeff">
<td valign="top" width="9%" style="TEXT-ALIGN: center"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">4.1</font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="89%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Certificate of Amendment to Articles of Incorporation (incorporated by reference from the Company&#8217;s Information Statement filed with the Securities and Exchange Commission on October 26, 2011.</font></font></td>
</tr><tr bgcolor="white">
<td valign="bottom" width="9%" style="TEXT-ALIGN: center"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><a href="aebf_ex991.htm">99.1</a></font></font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="bottom" width="89%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Press Release, dated November 15, 2011</font></font></td>
</tr></table>
</div>

<div>&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">2</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">SIGNATURES</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div>
<table border="0" cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="top" width="38%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Aemetis, Inc.</font></font></font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="35%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="top" width="50%" style="BORDER-BOTTOM: #ffffff solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Date: November 15, 2011</font></font></div>
</td>
<td valign="top" width="3%" style="BORDER-BOTTOM: #ffffff solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">By: </font></div>
</td>
<td align="left" nowrap valign="top" width="35%" style="BORDER-BOTTOM: black 2px solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">/s/ Eric A. McAfee</font></font></td>
<td valign="top" width="12%" style="BORDER-BOTTOM: #ffffff solid"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" nowrap valign="bottom" width="35%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Eric McAfee,</font></font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="35%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: normal; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Chief Executive Officer</font></font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div id="PGBRK" style="TEXT-ALIGN: center; TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">3</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>aebf_ex991.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<html>
<head>
    <title>aebf_ex991.htm</title>
    <!--Licensed to: Issuer Direct Corp.-->
    <!--Document Created using EDGARizerAgent 5.4.1.0-->
    <!--Copyright 1995 - 2009 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div style="TEXT-ALIGN: right"><font style="FONT-WEIGHT: bold">EXHIBIT 99.1</font></div>

<div>&#160;</div>

<div>
<div>&#160;</div>

<div style="TEXT-ALIGN: center"><img src="img001.jpg"></div>

<div>&#160;</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="74%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">For Immediate Release</font></font></font></td>
<td width="26%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td width="74%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
<td width="26%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td width="74%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Media Contact: </font></td>
<td width="26%" style="TEXT-ALIGN: left"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Investor &amp; Analyst Contact:</font></td>
</tr><tr>
<td width="74%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Andy Foster</font></td>
<td width="26%" style="TEXT-ALIGN: left"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">Todd Waltz</font></td>
</tr><tr>
<td width="74%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(408) 213-0928</font></font></td>
<td width="26%" style="TEXT-ALIGN: left"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">(408) 213-0925</font></td>
</tr><tr>
<td width="74%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">afoster@aemetis.com</font></font></td>
<td width="26%" style="TEXT-ALIGN: left"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; TEXT-DECORATION: underline">twaltz@aemetis.com</font></font></td>
</tr></table>
</div>

<div style="TEXT-ALIGN: right">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">AE Biofuels Announces Company Name Change to Aemetis</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">New Company Name Reflects Industrial Biotechnology Focus for Production of</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Renewable Chemicals and Advanced Fuels</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">CUPERTINO, Calif. &#8211; November 15, 2011 &#8211; AE Biofuels, Inc. (OTC: AEBF), an industrial biotechnology company producing renewable chemicals and advanced fuels using patented microbes and processes, announced today that its shareholders have approved a change of name of the corporation from AE Biofuels, Inc. to Aemetis, Inc.&#160;&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold">As of November 15, 2011, the stock symbol of Aemetis will be OTC: AMTX.</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">In June 2011, AE Biofuels acquired Zymetis, Inc., a Maryland industrial biotechnology company.&#160;&#160;The name Aemetis was derived from &#8220;AE&#8221; which means &#8220;The One&#8221; in Scottish, and &#8220;Metis&#8221; which means &#8220;Prudent Wisdom&#8221; in Greek.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#8220;Aemetis&#8221; means &#8220;The One Prudent Wisdom,&#8221; referring to the prudence and wisdom of replacing petroleum with renewable sources of chemicals and fuels.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The Aemetis Biorefinery technology platform is based on a unique patented aerobic marine organism (the &#8220;Z-microbe&#8221;) and propagation process that enables Aemetis to produce a variety of specialty biochemical and renewable fuels products for large markets using renewable feedstocks.&#160;&#160;Aemetis holds 4 granted patents and 14 pending patents on its microbial and enzymatic technology and production processes.&#160;&#160;Aemetis currently operates a 55 million gallon per year ethanol plant in Keyes, California and a 50 million gallon capacity biofuels plant in India.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#8220;Our scientists and operations teams at Aemetis are focused on the development and commercialization of innovative industrial biotechnologies that produce advanced chemical and renewable fuel substitutes for traditional petroleum-based chemicals and fuels,&#8221; stated Eric McAfee, Chairman and CEO of Aemetis. &#8220;By expanding existing first-generation biofuels plants to produce high-margin chemicals and advanced fuels, our technology platform helps biofuels companies increase their operating margins, decrease margin volatility, and diversify feedstocks and products.&#8221;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">1</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">&#160;</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">About Aemetis</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Headquartered in Cupertino, California, Aemetis is an industrial biotechnology company producing renewable chemicals and advanced fuels using patented microbes and processes.&#160;&#160;Aemetis operates a 55 million gallon biofuels plant in California, and built and operates a nameplate 50 million gallon per year renewable chemicals and advanced fuels production facility on the east coast of India.&#160;&#160;In 2011, Aemetis received a California Energy Commission grant to commercialize technology that enables the production of advanced biofuels from both non-food and traditional feedstocks.&#160;&#160;For additional information about Aemetis, please visit <font style="DISPLAY: inline; TEXT-DECORATION: underline">www.aemetis.com</font>.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Forward Looking Statements</font></font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">The information contained herein includes forward-looking statements related to future events.&#160;&#160;Statements regarding future events are based on current expectations and are necessarily subject to associated risks related to, among other things, the ability of the company to successfully commercialize its technologies, changes in government policy regarding renewable chemicals and fuels, the reduction or elimination of federal tax incentives or mandates, and changes in environmental regulations. Actual results may differ materially from those in the projections or other forward-looking statements made herein. For information regarding other related risks, please see the "Risk Factors" section of the company&#8217;s filings with the SEC.</font></div>

<div style="TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">2</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>img001.jpg
<TEXT>
begin 644 img001.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_VP!#``(!`0(!`0("`@("`@("`P4#`P,#
M`P8$!`,%!P8'!P<&!P<("0L)"`@*"`<'"@T*"@L,#`P,!PD.#PT,#@L,#`S_
MVP!#`0("`@,#`P8#`P8,"`<(#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`S_P``1"`"+`.8#`2(``A$!`Q$!_\0`
M'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`M1```@$#`P($`P4%
M!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!
M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$"
M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#]_****`"B
MBB@`HHHH`****`"BBC/?M0`PD<=3BH-1U.#2+-[BZFCMX(AN9Y&"JH]2357Q
M1XHL_!VB7&HW\RQ6UNN2>['LH'<D\`5X9$GB']I[Q#(YEDTSPW:28]5&.P_O
MR8ZGH/Y\]:ORVC%7;Z'G8W'*BU3IKFG+9?J^R.F\8?M56\5Z;'PY83:K=,=J
MR%6"$_[*#YF_2LJ*/XM>-T$N\:/!)T5BD)'X`%_S->I>!OAEH_P\LA#IMFD;
MD8>9ANEE]V;K^`XK8L;\7<]Q%TDMI-A'L0"#^1K!P;:56=F]DM/D<T<MQ-9.
M6)JM>4=$OGNSQ3_A17Q%8F0^+6#GM]ON,4Y](^+7@L;XKE=6BC'*JZ2EOP<!
MC^!KV1M0V>(TMB>MN9,?\"`J74;\6C0(3E[B0(O\S^@-9VIN+:DURNV_70MY
M%"ZY)RBWK=-_J>2>%OVIWL;X6'BG2YM.N5.UI$C9=ON8VY`]P3]*]9T?6[3Q
M!IT=W8W$-U;RC*R1MN4__7]JH^,?`6E>.M-:UU2TBN4_A<C#QGU5AR#]*\4U
MSPUX@_9GUTZCI4\M_H$[@2J_0?[,@'0XZ./_`*QV<ZE)^][T>_5&#KXK!N]=
M\]/NE9KU75>9]"L02.,YI2<DJ*PO`7C>S\?^'H=0L7)23Y70_?B;NK>X_48-
M;G&"#78I)JZ/9I5(SBIP=T]AU%%%,U"BBB@`HHHH`****`"BBB@`HHHH`***
M*`"BBB@`HHHH`:!@D'I28P#DX(IQX)]37/?$_P`3'PAX"U34%8++!`?+S_?/
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M(^QPF#]I9I:23B_*25_QLF=%+?C_`(6K#"6&3:%<?CFI+C43J?Q&M[9.4T^%
MG;TW,`/T!'YU\Z:W^T5%#^UE;ZHLK_V/:@:<^#QAEPS?A)^BU[/X0\2)I\^K
MZQ=$N[X"KW8L20H_(?A7/5S:%.K&E.2Y9U'-OHHQ2:^]H]?'\/U\)"%2<=94
MU;UD[->J3U]3L];UEA?6^FPOFYNOF<CK$@ZM]3T'O5W4-,M]5TZ6TN8DFMKA
M#&\;C*LI&"#7,^`%9X+O6[]U5[L\.YP$0>GH,_RK2TW6Y?%5TQM0\6G1'!E(
MPTY]%]%]3UKZ7+\T5:*JU/BJZQCU45LVNE]W?N?-8G"<MZ:VCN^EWNOT/&M+
M-Q^S?\8!9222-H&K$;2QR`A.`Q_VD)P?4'WKZ#4Y&0>*\W_:A\(+XA^&\MY&
MN;G1W%PA[[.CCZ8Y_P"`UJ_`;Q2_BOX8:;/(Y>>W3[/(2<DE.`3[E<'\:]>A
M[DW3Z;K]3Y;`IX;$SPGV6N:/DNJ^\[6BBBNP]L****`"BBB@`HHHH`****`"
MBBB@`HHHH`****`"BBB@!&Z@^E>8_M87AM_A88QG%S=1HWT`9OYJ*].;J!ZU
MYI^U98-=_"J2102+6YCD/L#E?YL*PQ%_92MV//S6_P!4J6[,V_A3:R:-\)="
M2WA,S+9I(4!"L=R[CC/&<GO6A)XWTN\$EI>E[5V&UHKB,IG/Z?K5#X.:U#=_
M"30YY)$1!:I&22``5^4C\Q4WB37/#NJP-%>7%O,5Z;22R_0CI7BYG7G2HJ5.
MK%:?#.UFK=[IK\3T\HIPE1IKE;5EJMUHCF-76;P5<NUG,EWI-YD%-V],$<J<
M=#CH:\[^)GB[_A#O!M[>HY#!=D*D]7;A?RSG\#74:O#:6]RRV5Q+/"W]]"A'
M^/UKPS]H[Q+)K/B.ST*W8G[.0T@S@&1^%!^@_P#0J_%DIXS'1I)6A%MV3YDE
MU2:Z-[(_5^'\!&M6ASZ]9-JVB[KOTN<=;>!+J_\`A]>>(27*P7`7_?7^)_P8
M@?G7N7P?\8?\)CX&M))'9[BW_<SC/.]0!N_%<&C2='TFP\#Q:#)?6;0FW,,G
M[Y?F)'S-U]237FOP*UM_!WQ!N]%N9`8[MFB!!RID0G:1]1D?E7;CHUL7AZCE
M%IP=XW35UV_`^CQ&-IYI0JJ#3E3?-&W\NWZ7/I72TN/&=Q%'<RK::3:`*5W`
M*`!P.>K'UKL(O&^DZ<B6EFS7#QC8D5NA8_X?K7FFDPVT]PJ7D\L$"\DHI<G\
M.WUKT3PWK?AO28!':7$$3-]XOD,WU)KW>$,PJ2NW.$9/>4FG)I;)*ZLETOIY
M'Y;F^'BK63:6R2LEYMZW;+WB**37/!>IQ3PF$7%K(FPD,>4/7'%><?L=7CR>
M#=4MW.1%=!Q_P)%!_P#0:](\7ZU!;>"M4O$EC>."TE?<I!'"&O.?V/+!X?!>
MI7+@`376P>^U%_JU?J47^\A[W-H]>_W'YWB_^1E2LK:2NO+3]3V('(!]:***
M[CV0HHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`****`$`&[.>M8?Q#\,_
M\)AX,U+3AC?<PLJ$]`^,J?P8"ML=`>F*,@X&,DU,E=-&=2FIQ<);/0\<_90\
M3B?1-0\.W8(N--F,JQN.0C'##'LV?^^JZ/QWXLMHYGL]'\,S>)=14X;R8UCM
MH3_MS'Y0?89/TKA_C+X>O?A#\2;?QCI,9-I<R?Z1&O"[S]]6]G'(/9L^U>P^
M#/%EEXV\.VVHZ?(KV\R_='!1NZD=B#7'1IT97I8B"ER]'LT>1E6(J4D\$Y.,
MX;/NNC7Y'@7CKX;>/+G1;_6=6OM&\,:=90O-)!:NS,J@9VY&22>GWNIKRO\`
M9\^"]S\>?%M^TU[-:6]D@EFN3'YK%V.%3DCD@,>O:O8_V]/B5_9'A>Q\,VTH
M$VJ-Y]R`>1$AX!_WF_\`0377?LA_#G_A`?@]9S2H4OM9/VR8,,$!ON+^"8_$
MFN1JE+&0I8>G&$8>\U&*2OTOIKTW/U;`QEEW#]7%U)-U,1[L;MM\NO-;M?7\
M#EO^&#++OXDN\_\`7HF/_0J\A_:/^`D_P*U/3+JWOY;^VO\`<%G\KRFBE3!V
M\$]000?8U]O'/4D\UYS^U%\//^%C?![4[>.,/>6*_;+7UWH"2!]5W#\:]3.*
M]?%8=PF[VU6BW7R^1X'!N)HY=FD*EK1G[LM[6EW]'9GD_P`,OAWXXOO"FFZ_
MHNI:5K]C>1"06EY(P(/1D)/0@@CANU>L^"/%B02I9^(?"TWAN^.%65D$UG*?
M]F89"GV;'U->5?L"_$K>FI^%KF7#+_IMF"<C!P)%'X[6Q_M&OHKQ!KEIX;T:
MXO=0F2*U@0L[-TQZ>^>F.]<N$^I5Z2KRH04GNU%)WZW:T^]&7$>6ULLQU7#^
MTDH)W2;;7*]5OV1Y[^U+XNC\/_#T:7$56XUAQ&%7@B-2&8_R'XUT_P`$_"C^
M#OAMIEI(I6X=/.E!ZAW.X@_0''X5Y7X(T^Z_:$^+3Z]?1/'HNF.!%&W3"G*1
M_4GYF_+N*]_`"=.U7AUS2=3ILO0^-P#>(Q$\8]K6CZ+=_-CJ***[#VPHHHH`
M****`"BBB@`HHHH`****`"BBB@`HHHH`****`"BBB@"CK>CVWB#3)K.[B2>V
MN%*2(W0C^A]^U>%:OX<\1?LU>(I-1TC?J'A^Y;,D;9*X]'Q]UAV8<']*^@AG
M&#UJ.6!)XV1T#JPP0PR"/2L*M)3LT[-;,\_&X"->TXOEFMI+=?YH\7M/#_PV
M_:+US^T]0@D;6ID5'M[BZDBD4*/NJ`P4CK]WZU[-;6Z6MO'$@`CB4*H]`!@5
MYIX[_9=T7Q-,]Q8.^D73\XC7=%GUV\$?@0/:N;C^'/Q/\$$KI>L'4($^XAF6
M08^DHX_`USPYJ;;<-7NUU]2*F<9FH1HXR,JD8Z1<7=)>2>WR/=2#V(%,EC$L
M95\$$8->'CQ#\8`-AT^)FZ;O)A_^*Q39/!7Q5\9A5O\`5/[.B?AU$J1<?]LP
M2:MXJ_PQ;^1A_;#>E.C-OTM^)?U;P%\,O@3KD6L+"]OJ]NQDAB@NY'F8D$$;
M-V,')'S<5@"/Q)^U!K\9D1],\.VTF<=4'_Q<GZ#V[]=X*_94TK1KA;K6+F76
M+HG<5.4B)]^2S?B<>U>H6EG%86Z0P11PQ1C:J(H55'H`.E13PSDK-*,>RZ^I
MMBY9CFDU/,9OE7V;MMKLWV\D4?"OA:R\&:+#I]A"(;>`8`ZECW8GN3W-:PSW
MI,<Y.*7(P>>E=R22LCT(0C&*C%62"BBBF:!1110`4444`%%%%`!1110`4444
M`-+GZ4H'RX(K+UCQGI7AZZC@U#4]/LII1N2.>X2-F&<9`)Y&:U%;.3GBAQ:2
M;6Y*DGHA:-P!P3S1FL^X\4:=:3/%+J-C%)&<,K3HK*?0@GBB*;V02DEN:%%9
MO_"8Z3_T$]._\"4_QH_X3'2?^@GI_P#X$I_C5^SGV)52/<TAGN<T56T[4K;4
MXC);7$-P@."8G#@'TR*AN?$^G6<S13:A912H<,CSHK+]034J#O:Q3DM[EX*0
M<DTM5K#5[75%9K6Z@N0APQBD#A?KBK-#36XT[A2;L'&*&8(I+$`#DD]!6=_P
MF.DY_P"0GIQ'_7RG^-"BWLA2DEN:5!4'DBH8KB.XMUFCD22)QN#JP*D>N?2J
M8\8:2!@:GIY_[>4_QHC!O9`Y);LTJ*S?^$QTG_H)Z?\`^!*?XT?\)CI/_03T
M_P#\"4_QJO9S[$^TCW-'8/2C:!T%0+J%NUE]I$\)MRN[S0X*8]<],55_X3'2
M?^@GIY_[>4_QJ5&3V13FENS2HK-_X3'2?^@GI_\`X$I_C1_PF.D_]!/3_P#P
M)3_&J]G/L3[2/<T@H'(%!4'DBJ5CKMCJCE+6\M;ET&2(I5<@>O!IMSXETZSG
M:*?4+**5/O(\ZJR_4$U/)*]K%<RWN7LGJ1@4M4;+Q!I^H3^5;7MI/+C.R.97
M;'K@&KI;'`Y)H::W&I)[`,/U'2E`QP*SM7\3Z;X?4&^U"RLL]//G6//YD5!8
M>/=#U5@EMK.EW#MP%CNXW)_`&FJ<GLM"'4C>US8HI%8%0<@@T5-S0`,X/0T-
M@#)X`I!G@@'`KBOV@/'1\`_"S4KN.39=7"?9K;'7S'XR/H-S?A5TJ;J34([M
MV,ZE10BYRV1\U?'74KWXC>+M<\20J9-(L+M-.BDSQ@*VW'L=I;_@8]:^G?@?
MXO'CCX6Z/?LYDF,`AF/<R)\C$_7&?QK@_#OP;V_LISZ6T0-_J%L=2(QAO-X=
M%^NU57\ZR?V'/%IFT_6="E<DP.MW"">Q^5\?0A/SKWL:XU\+)4_^7;LO3:_S
M9Y&&YJ>(3G]M7^>Y[^PSC'>OG/\`;5\%:?H\>FZQ:0);WEY/(EPT8VB;C(9A
MZ]>>^:^C5YR<5X7^W7_R*.B'_I[?_P!`KS\GE)8N"3W_`,CKS**^KRNMO\R;
MX(?`3PMXN^%FD:EJ&G/<7ES&[22?:95W$2,.@8#H!6EX\_9/\.:GX9NET>VG
ML=22,M;N+AW5G`R%8,3P>F>HS70?LU$#X):`"5R(G_\`1KTNK?&VTL/B_IOA
M&&!;JXO4+2SK*`+9MKL%(QR<+ZC[PK6IB<5]9G[.3]UM[Z63,X4:'L8\Z6J2
MVUNSE?V*;.:R^'^JQSQRQR#43D.I4_ZM/6L/]M7P3IUAHECK=O;Q6^H7%YY,
M\B?*9@8R<MCJ1L'/7%?0*@*<`<5XO^W!D_#C2QV.I+_Z*DHPF)E4QRJK2['B
M:"AA'!ZV1P7[*VOW/P\^,-WX?U!C&-20P$$DCS4RR$'T(W`>NX5]2X&1BOEC
M]HW0KCP9XE\+^+;$%&O+:WD9QP!/$J8)^J[?^^37TKX6\00^*_#=CJ=N<Q7\
M"3K[;AG'U'3\*O-TJCAB8_:5GZHG+9.'-0E]EZ>C.-_:;\=GP/\`"J],3E;S
M5/\`0H`#AOG!W$?1-WXXKYR^#/@5=6^-VG:'K$9=(YG\^$L<,41FVG'N`#^-
M>N^.@WQC_:7TS1%)DTOPNOVBY'.TN"K,#ZY/EI_WU7%?"^4S?MAW#DY+:C>C
M]):[\#^YPTX1TDXN3^>WX:G)BW[2O&7122_S/I^RTVWTW3HK."&*&UA01I$J
M@(B@8V@>F*^3/VK_``98^!_B5%%ID"6=M=V:3F&/A%;<RG`[#Y1P.*^O>.,<
MYKY8_;>_Y*9I_P#V#E_]&25PY%4E]:M?=.YUYM%>PO;9H]>TW]F;P7/IMM(^
MDN7DB5B?M4PR2!_M5Q/Q_P#V9=*TCP5<:KX=M[BVNK##RPB5Y%E3."1N)((Z
M\=@?:O<]&D5=&M,LHQ"G4_[(KD?!/QJM?'?Q$UK0K2!7ATA<_:UE#K,0P5@`
M!P`2><GI6%+%XI5'4BVU'5W>EKFE3#X=Q46DG+1>IS.D1/#^QQ.KJRR#2)\@
M\'.7KC?V:?V>=-\:>%'UO7HY[E+B1H[6'S6C3:IP7.,$G=D`9QQ^7T5?Z?!J
M=A);7,4<]O.I22.10R.#U!!ZBFZ7I5MH]A':VD$5M;0C"11($1!G.`!TYI1S
M*4:<XPT<I7OY=BW@HRE%RU458^3/VI_`FE_#OQU8V>D0/:V\UDLKKYK/EM[C
M.6)/0"O:?^&6O".M^&(ECLY[2XGMU(GCN9"R,5'S88D'GL17EW[;_P#R4W3O
M^P<O_HR2OIG0,_V#9`]#!'_Z"*[L9BJL<+1G&33=[Z[[;]SCPU"G*O4BXJRM
MT/G_`/9'\/7/A/XM>)M+N\F>QA:%CV.)5&1['K^-7OVU/!6G6/A^SURWMD@U
M&>]$,TD?RF93&QRV.I&P<]<5[?;>';"QU>XOX;*VCOKL!99TC"R2@8P&8<GH
M.OI7D_[;Y_XM?IY]=27_`-%25EAL6ZV/A4VO9/[M36MAE2PLH/6UVOO)/V/O
M!.GVGPYM];^S1R:G>23*;AOF=5#;=JYZ#Y<\=<UK_M.?%>Y^&'@B,Z>=FHZF
MY@ADP#Y*@99QGN.`/=L]J/V1VQ\#M-_ZZS_^C6K'_;)\!WGBGP-9ZA91O,=&
MD9YD49;RV`RP'?!49]B3VJ&HSS)JJ[KF:U_!#]Z."3IJSLMOQ(?@E\`=)\0>
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M4@BM[.)II6/`55&2?R%>#_LMZ:/B1X[\4>+=2BCF>:3RHE<!PA<[B,'CY550
M/8UZN6I0Y\3):16GJ]#AQS<N6C'>3_!:G=K^U-X&2,(-3E"J,`"SEP/;[M>$
M?"3Q;8^#/VCHYM.G\S2+Z\>U1RA3,4IP@P>1@E>O]VOK+_A'-/S_`,>%GC_K
M@O\`A7S9^V=X4C\-^-])U:T1;9;V$J?+4*%DC8?-QWPR_E7;E=6A.<J$4USI
MK5I_HCFQ\*L8QJR:?*T]$U^K/I\$<GL.:\+_`&ZO^10T0^MV_P#Z!7K'PX\4
MIXV\"Z5JJD$WMLKOCL^,./P8$5Y1^W4<>$-#_P"OM_\`T"N+*XN.-A%[IO\`
M)G5CY*6%E)=4OT(_@M^SOH'B_P"%^DZG=R:D+F[C9G$=R43(=AP,<<"H=$_9
M[NOAS^T3HE[ID-Y=:&0\KSOAOL[&.12K$8[XP?\`:KT/]FD9^!^@CUB?_P!&
MO79ZEJ,.D:=<7=PXB@MD:61CT55&2?R%57Q]:-:I"]TVU8BE@Z4J4)VLU9W+
M`SN/H*\8_;?/_%N-+'_427_T5)72?L^?%N^^+VB:I?7EO;6ZVMWY$*Q*PRNT
M-SDG)Y'3%<U^W`?^+<Z6/74E_P#14E1@:4J>-A">Z9IBZD9X:4H[-&K\8/`_
M_"<_LZ11HF^[T^QAO(.,G*1@L![E-P^N*Y3]F;XP1:'\%M<CO'W/X95I8U)Y
M='R57_OYD?\``A7L_@U1+X,TE"`RM91`]P?W8KY)\4?#*_TCXU7OA*R:6*'4
M[I8T4<*\+,'4D=PHP?JIKNP"A7IU,/5=DGS+TOK^!RXIRI2A6@KW5O\`(]P_
M9*\+36_A;4/$E^"^H>)+EIBY&&,88\_BQ8_3%>8?";_D[V?_`+"-]_*6OJ'1
M-'@T#1[6PMU"06<2PQKZ*H`'\J^7OA*1_P`-?3DG[VHWO\I:,'7=5XB?>+^[
MI^`L12]FJ,>TE_P3ZL7H*^6?VWQGXFZ>/73E_P#1DE?4P!``]*^6?VWC_P`7
M/T\#J-.7_P!&25S9%_O2]&;9K_`?JCU"Q_92\,7FEP,TNK@RQ*3B[XY'TK(_
M9Y^#NI?"SXK>(8YX+A],,/EVMVZ@+.-ZL.G?'7W!KV30_P#D#VOIY*?^@BL3
MXL>.E^&_@#4=7(C:2U3$*/G:\C'"@XYQD\X[`UBL;B)N5&_-S::^IK+#48VJ
MVMRZZ>ATO7J*3[H)[5S'PA\87?CSX=Z;JUZD,5S>HS.D((08=@,9)/0#O73%
MCR#WKSZD7"3C+=.QV0FI14ELSY;_`&W_`/DINF_]@Y?_`$9)7TSX=_Y`5E_U
MPC_]!%?,W[;Y_P"+G::,X(TY?_1DE?3/APYT&R/K;Q_^@BO9Q_\`N=#YGFX3
M_>:OR+@^\?:O&/VX/^28Z?\`]A)/_14E>SC[QKQC]N#_`))EI_\`V$D_]%25
MR97_`+W#U.C,/X$_0V_V1_\`DAVF9Z"6?_T:U>E[`000"#U%>:?LBD'X'Z:"
M.DT__HUJTOBC\:[;X7>)-"L+JU:6+6)"C7'F!1;`,JEB,<CYL]1THQE.=3%S
MA!7=V&'JQAAX2F[*R.:^*7[(^B^-7EO-)8:+J$F6*HN;>0^ZC[OU7CV->3:#
MXX\7_LP^*TTS4EEET\G<UL[EH)4)Y>)NQ]QWZBOK?@KN!ZUX?^W'';'P/I#.
M%-VMZ1'_`'MA0[OPSL_2NW+<;.K-8:O[\9::[KYG+C<-&G%UZ7NM=NIZ_P"'
M/$-OXHT"TU.T9I;:^B66,D8.",X([$="/6BN2_9IL9]+^!V@17"MYC1R2C)R
M=KRNZ_\`CK"BO*K0C"I*"Z-K\3U*#<Z<9/JB+XX_#OQ)\2].72],U*PT_29$
M4SAU?SIG#$[20"-GW3CJ2#GBL+X)?!'Q5\'M0:./5='N=,NY5:ZA9)"^!P60
MX&&QZ\5["Q.T4J\`5<,;4C2=!6Y7Y(QEA(.I[;6_J(<]<@8KQ7XR?`7Q9\8-
M6BDN]6T:&TLV<6L,:2#:K$<L2#EB`,]N*]K_``II)P.348;$3HSYX6OZ%UJ$
M:L>26QYE\#/A7XE^%$!TZ[U/3KW1B6D6-5?S8G./ND@`*3U!_P`<Y?QO^!?B
MGXPZH@DU72;?3+-V-I"$D#@''+G!RW';BO8QW'I2-V%:+'U8U?;JW-Z(S>#I
MNG[+6WJ>/>%/A5\1?!F@6VF6'B;1XK6T!5%-MN(!8GJ4R>2:A\8?"#XC>.-&
MDT^_\5Z<;2;B1(X3%O&>A*H"1[=*]F'4^U(">/I5?VC4Y^:ROO>RW^X3P4.7
MEN[>K.#^`7PEN?A#X3N=.N[J"[FN+HS[X@P4`HJXY[_*?SK`^./P6\3_`!BO
MTA75=*MM)M)/,MX0CB3)7&YS@Y/7&,#!KUU22.>:"-N,<9-1#&556=?3F?D5
M+#0=-4>B.3^%/A[7_"WAQ-/UN]L+\6B)%:R6Z,K[%&,/G@D8&"!]:Z5K&!KH
M3M#$9E&!(4&\#Z]:F&2Q![4ZN>I4;;D^O;0VA!1BH]C(\5PZK<:)*FB2V45^
MY`1[M6:-1GDX7G..G:O$-!_91\5>'/&46O6^O:8=2BF:?S'5R'9L[LC;R#DY
M^M?09)!P#@"G%0`2!S71AL;4HQ:A;WM]$SGK8:G5DG*^FVI2TQ+U=)@%X;=K
M\1#S#$&$1?'.,\[<^O->'_$;]F#Q7\4O$KZIJ>LZ.)R@B5(4D6-$&<*`03U)
M/)/6O?0HP.*0_*#CCFEAL74H2<Z=DWY#K8>%9*,]D>70>#?BA;0QQKXIT54C
M4*!]D'0#'_/.N=\>_L^^._B9#%#J_BC3[B"%MZQ+&8T#8QG"H,G!ZFO<TZD=
MJ=6L,PJ0?/%13]%_D*6#A)<LFVO5_P"9S_PR\(R>!O`>FZ1-+'-+8Q>6SH"%
M8Y)R,_6MB\$WV67R-GG!#LWYV;L<9QSC/I4X^\?:@'DCTKCE-RDYO=ZG1&"B
ME%;(^?\`XA_LO>*_B=XC;5=4UO2&N'18U6-)%CC4=%48/&23R3UKU/X7:%XC
M\,Z&MAKM[I]\EJB16TMO&ZR;0,8?/!.,8('UKK>X':@'YC736Q]6K35*5K+;
M1:'/3PE.G-U(WN]]=P/3.<5Y)\<_@QXF^,5XMNNIZ9;:1;2>9;P['$A;;C<Y
MP<G.<8XP:]<IFX^IK+#UYT9^TIVOYJYK6HQJQY);'FOP*^%_B3X4VITV]U'3
M+W1_GD5$5_.C<XZ$@#;U)!]:=\?/@&WQG;3Y8]3%A-IRN%#0^8LFXJ>H((QM
M]^M>DCE3FG;1Z5<<;4]K]8B[2]$9_58>S]B]4>.^'?`GQ6\)Z<EE:Z]X<OK6
M`!(FO/-:15`P!D1Y_,FHU_9NU?Q[XDM]4\<:ZFHFV/R6=HA6$#.=H8A<`]\+
MD^M>RN.,]Q0HW+SSBK68U$W*-DWU22?WB6"A9)MM+HVR&WM8[2VCAC58HHE"
2(J_*%`&``/0"BIZ*Y+G6C__9
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
